Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > warrants Aug 22

<< Previous

Bullboard Posts

Next >>

Comment by riverrrowon Aug 19, 2024 4:13pm

176 Views

Post# 36186617

RE:RE:warrants Aug 22

Waiting to fill a second tranche until after the tradeable warrants expire is not a nice way to treat the little guys supporting TLT. I'm holding over a million warrants at over 10 cents a warrant average cost. Five years ago the leverage the warrants provided on the blue sky potential of Ruvidar was astronomical.

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth